Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001214659-23-014538

Director acquired 2,814 shares (code L)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Krogulski Kenneth Director 2023-10-17 Other acquisition 10b5-1 +280 $2.24 $627 222,473 D
Krogulski Kenneth Director 2023-10-18 Other acquisition 10b5-1 +280 $1.96 $549 222,753 D
Krogulski Kenneth Director 2023-10-19 Other acquisition 10b5-1 +280 $2.05 $574 223,033 D
Krogulski Kenneth Director 2023-10-20 Other acquisition 10b5-1 +64 $2.08 $133 223,097 D
Krogulski Kenneth Director 2023-10-23 Other acquisition 10b5-1 +255 $2.08 $530 223,352 D
Krogulski Kenneth Director 2023-10-24 Other acquisition 10b5-1 +280 $2.10 $588 223,632 D
Krogulski Kenneth Director 2023-10-25 Other acquisition 10b5-1 +280 $1.99 $557 223,912 D
Krogulski Kenneth Director 2023-10-26 Other acquisition 10b5-1 +280 $1.99 $557 224,192 D
Krogulski Kenneth Director 2023-10-27 Other acquisition 10b5-1 +280 $1.98 $554 224,472 D
Krogulski Kenneth Director 2023-10-30 Other acquisition 10b5-1 +255 $2.04 $520 224,727 D
Krogulski Kenneth Director 2023-10-31 Other acquisition 10b5-1 +280 $2.01 $563 225,007 D
Loading xslF345X05/marketforms-63457.xml…